A combined approach for the study of histone deacetylase inhibitors

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Histone deacetylases (HDACs) regulate gene expression through histone deacetylation.
• HDAC overexpression is linked to tumor suppressor gene silencing and cancer development.
• HDAC inhibition is a potential therapeutic strategy for various cancers.

Purpose of the Study:

• To establish a comprehensive method for evaluating HDAC inhibitor efficacy.
• To investigate the impact of HDAC inhibition on histone acetylation patterns.
• To explore potential mechanisms beyond direct HDAC inhibition that influence therapeutic response.

Main Methods:

• Preliminary screening involved measuring HDAC activity and histone H4 modification profiles using MALDI-TOF MS.
• Detailed analysis of histone modification forms utilized 2-D AUT/AU PAGE and LC-ESI-IT MS.
• The study employed a multi-level approach to assess global histone acetylation status.

Main Results:

• The developed methodology provides global insight into HDAC inhibitor effects on histone acetylation.
• Valproic acid sodium salt and entinostat, at similar HDAC inhibition levels, induced different rates of histone hyperacetylation.
• The findings suggest that additional molecular mechanisms, beyond direct HDAC inhibition, contribute to the observed responses.

Conclusions:

• The multi-level approach effectively monitors individual and combined histone modification dynamics.
• Distinct histone hyperacetylation rates indicate complex responses to HDAC inhibitors.
• Further research into amplifying mechanisms is warranted for optimizing HDAC inhibitor-based cancer therapies.